Multivariate landmark analyses at 6 mo for subsequent FFS, OS, and NRM
| Outcome . | Parameter* . | No. events/no. at risk after excluding missing . | P . | HR (95% CI) . |
|---|---|---|---|---|
| FFS | Change in 2005 NIH 0 to 3 skin score | 112/211 | .001 | 1.53 (1.19-1.96) |
| Change in patient 0 to 10 skin itching | .002 | 1.15 (1.06-1.24) | ||
| OS | Change in Lee skin symptom score | 64/308 | .005 | 1.02 (1.01-1.04) |
| FACT-BMT total score | .04 | 0.98 (0.97-0.99) | ||
| NRM | Change in Lee skin symptom score | 48/326 | .001 | 1.03 (1.01-1.04) |
| Outcome . | Parameter* . | No. events/no. at risk after excluding missing . | P . | HR (95% CI) . |
|---|---|---|---|---|
| FFS | Change in 2005 NIH 0 to 3 skin score | 112/211 | .001 | 1.53 (1.19-1.96) |
| Change in patient 0 to 10 skin itching | .002 | 1.15 (1.06-1.24) | ||
| OS | Change in Lee skin symptom score | 64/308 | .005 | 1.02 (1.01-1.04) |
| FACT-BMT total score | .04 | 0.98 (0.97-0.99) | ||
| NRM | Change in Lee skin symptom score | 48/326 | .001 | 1.03 (1.01-1.04) |
Models include the enrollment value for the significant change scores and adjustment for baseline characteristics.